1.
van de Sande M, Tap WD, Gelhorn HL, Ye X, Speck RM, Palmerini E, Stacchiotti S, Desai J, Wagner AJ, Alcindor T, Ganjoo K, Martín-Broto J, Wang Q, Shuster D, Gelderblom H, Healey JH. Pexidartinib improves physical functioning and stiffness in patients with tenosynovial giant cell tumor: results from the ENLIVEN randomized clinical trial. ActaO [Internet]. 2021 May 12 [cited 2026 Aug. 24];92(4):493-9. Available from: https://scandjms.sfulib10.publicknowledgeproject.org/index.php/actao/article/view/1190